Cargando…
α/β-Hydrolase Domain (ABHD) Inhibitors as New Potential Therapeutic Options against Lipid-Related Diseases
[Image: see text] Much of the experimental evidence in the literature has linked altered lipid metabolism to severe diseases such as cancer, obesity, cardiovascular pathologies, diabetes, and neurodegenerative diseases. Therefore, targeting key effectors of the dysregulated lipid metabolism may repr...
Autores principales: | Bononi, Giulia, Tuccinardi, Tiziano, Rizzolio, Flavio, Granchi, Carlotta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389839/ https://www.ncbi.nlm.nih.gov/pubmed/34213320 http://dx.doi.org/10.1021/acs.jmedchem.1c00624 |
Ejemplares similares
-
α/β-Hydrolase Domain-Containing 6 (ABHD6)— A Multifunctional Lipid Hydrolase
por: Pusch, Lisa-Maria, et al.
Publicado: (2022) -
Application of MM-PBSA Methods in Virtual Screening
por: Poli, Giulio, et al.
Publicado: (2020) -
Discovery of Triterpenoids as Reversible Inhibitors of α/β-hydrolase Domain Containing 12 (ABHD12)
por: Parkkari, Teija, et al.
Publicado: (2014) -
Machine Learning-Based Virtual Screening for the Identification of Cdk5 Inhibitors
por: Di Stefano, Miriana, et al.
Publicado: (2022) -
α/β Hydrolase Domain-containing 6 (ABHD6) Degrades the Late Endosomal/Lysosomal Lipid Bis(monoacylglycero)phosphate
por: Pribasnig, Maria A., et al.
Publicado: (2015)